Free Trial

Anpario (LON:ANP) Stock Passes Below 200-Day Moving Average - Time to Sell?

Anpario logo with Consumer Defensive background
Image from MarketBeat Media, LLC.

Key Points

  • Anpario's shares passed below its 200‑day moving average (200‑day MA GBX 497.17), trading as low as GBX 410 and last at GBX 424.40 on volume of 34,535, and are also below the 50‑day MA of GBX 515.59.
  • Analysts remain positive: Canaccord raised its price target to GBX 570 with a "buy" rating, and the consensus rating is "Buy" with a consensus target of GBX 570.
  • The company shows solid fundamentals with a market cap of £71.92m, a P/E of 14.28, strong liquidity (current ratio 4.32, quick ratio 5.16) and low leverage (debt/equity 0.22), which may offset recent technical weakness.
  • Five stocks we like better than Anpario.

Anpario plc (LON:ANP - Get Free Report)'s share price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 497.17 and traded as low as GBX 410. Anpario shares last traded at GBX 424.40, with a volume of 34,535 shares traded.

Analyst Ratings Changes

Several equities analysts recently commented on ANP shares. Canaccord Genuity Group boosted their price objective on shares of Anpario from GBX 550 to GBX 570 and gave the company a "buy" rating in a research note on Thursday, January 22nd. Shore Capital Group reiterated a "house stock" rating on shares of Anpario in a research note on Monday, January 19th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat, Anpario currently has an average rating of "Buy" and a consensus target price of GBX 570.

Read Our Latest Report on ANP

Anpario Trading Up 2.3%

The firm has a fifty day simple moving average of GBX 515.59 and a two-hundred day simple moving average of GBX 497.17. The stock has a market cap of £71.92 million, a PE ratio of 14.28 and a beta of 0.92. The company has a current ratio of 4.32, a quick ratio of 5.16 and a debt-to-equity ratio of 0.22.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines